--- title: "Profil World #1 - Introducing Profil's Diabetes Newsletter" description: Profil Germany launches a new diabetes newsletter with Information around the world of diabetes research. Sign up now. image: https://blog.profil.com/hubfs/fotomainz.jpg --- [![profil-logo-wortbild-with claim-4c-offset_1000px](https://blog.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) ![Header_1077x260px_About_Profil.jpg](https://blog.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg?width=1077&name=Header_1077x260px_About_Profil.jpg "Header_1077x260px_About_Profil.jpg") # Profil World #1 - Introducing Profil's Diabetes Newsletter ![Tatiana](https://blog.profil.com/hubfs/Mitarbeiter/tatiana_hexagon.png) Posted by [Tatiana Dicenzo](https://blog.profil.com/blog/author/tatiana-dicenzo) on Jun 18, 2015 3:00:00 PM ![Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.](https://cdn2.hubspot.net/hub/3825816/hubfs/BM/IN.png?width=20&name=IN.png "Two clicks for more privacy: The linkedin Share button will be enabled once you click here. Activating the button already sends data to linkedin.") ![Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.](https://blog.profil.com/hubfs/BLUE_MOON/twitter.png "Two clicks for more privacy: The Twitter Share button will be enabled once you click here. Activating the button already sends data to Twitter.") Dear Reader, Welcome to the first "Profil World"- our new once per quarter newsletter, which will help to keep you updated on recent news in the world of diabetes clinical trials! ### **Relevant Scientific News** [![Nature Medicine paper](https://blog.profil.com/hs-fs/hub/481167/file-2597960166.jpg?width=122&height=81&name=file-2597960166.jpg "Nature Medicine paper")](https://blog.profil.com/blog/translational-diabetes-research-in-nature-medicine)In the past months, Profil has launched a new blog, where we discuss relevant current topics. Read more about our **[recent Nature Medicine paper](https://blog.profil.com/blog/translational-diabetes-research-in-nature-medicine)** on the cough suppressant dextromethorphan and its role in Diabetes. Or learn about Profil's involvement in the **[new business consortium EIT Health](https://blog.profil.com/blog/for-healthy-living-and-active-ageing-profil-has-joined-eit-health)** to promote healthy living and active ageing of European citizens. Lastly we want to highlight our review of the **[new EU clinical trial regulations](https://blog.profil.com/blog/the-new-clinical-trial-regulations)** and how they will affect conduct of clinical studies in Europe.  ### **New online seminar series on clinical research and development in diabetes** [![Webinar about alternative route insulins](https://blog.profil.com/hs-fs/hubfs/Eric_video.gif?width=122&height=81&name=Eric_video.gif "Webinar about alternative route insulins")](https://info.profil.com/webinar-on-demand-alternative-routes-insulins)Profil has launched a new series of scientific online seminars. **[The first online seminar](https://info.profil.com/webinar-on-demand-alternative-routes-insulins)** discussed the opportunities and challenges during the development of alternative route insulins. Our next online seminar will review **[novel molecular pathways](https://info.profil.com/webinar-future-diabetes-treatments-novel-pathways)** that may be addressed by future diabetes treatments. It will also address what to consider in the preclinical stage of drug development to successfully move a novel drug to the clinical stage. Secure your spot for our live online seminar **on July 14th** by **[registering here](https://info.profil.com/webinar-future-diabetes-treatments-novel-pathways).** ### Profil opens second clinic in Mainz, Germany [![Profil clinic in Mainz](https://blog.profil.com/hs-fs/hubfs/fotomainz.jpg?width=122&height=81&name=fotomainz.jpg "Profil clinic in Mainz")](https://info.profil.com/profil-mainz)In order to increase our clinical study capacity, in 2013 Profil founded a second clinical unit in Mainz, Germany. The location of this new site gives Profil better reach into one of Europe’s largest metropolitan areas. With this reach into the Frankfurt/Rhine-Main region, Profil will be able to further accelerate the growh of its large database of volunteers with with obesity, type 2 and type 1 diabetes.  **[Read More...](https://info.profil.com/profil-mainz)** ### **Meet us at upcoming conferences** ![Meet Profil at conferences](https://blog.profil.com/hs-fs/hub/481167/file-2568984664.jpg?width=122&name=file-2568984664.jpg "Meet Profil at conferences")Are you interested in knowing Profil better? Would you like to learn more about our proprietary automated glucose clamp system- ClampArt? Do you want more information about our clinical trials? Profil regularly attends the most important meetings. Use this great opportunity for a meeting with us. Write us n email at [marketing@profil.com](mailto:marketing@profil.com) and let us know, if you want to meet with us at one of the upcoming meetings.   - 51st EASD Annual Meeting, Stockholm, September 14-18, 2015 - 15th Annual Diabetes Technology Meeting, Bethesda, October 22-24, 2015 - IDF 2015 Vancouver World Diabetes Congress, Vancouver, November 30 - December 4, 2015 We wish you a good week and look forward to the next "Profil World", All the best, Tatiana Dicenzo Topics: [About Profil](https://blog.profil.com/blog/topic/about-profil) [Leave a comment](https://blog.profil.com/blog/profil-world-1-introducing-profils-diabetes-newsletter#comment_form) ### Subscribe to Email Updates ### Our most popular Posts ### Posts by Topic - [Clinical Trials in Diabetes (127)](https://blog.profil.com/blog/topic/clinical-trials-in-diabetes) - [About Profil (69)](https://blog.profil.com/blog/topic/about-profil) - [Clinical Trial Methods (68)](https://blog.profil.com/blog/topic/clinical-trial-methods) - [The Science behind Diabetes (64)](https://blog.profil.com/blog/topic/the-science-behind-diabetes) - [Treating Diabetes (62)](https://blog.profil.com/blog/topic/treating-diabetes) - [Diabetes Technology (41)](https://blog.profil.com/blog/topic/diabetes-technology) - [Clinical trials in Obesity (11)](https://blog.profil.com/blog/topic/clinical-trials-in-obesity) - [Events (4)](https://blog.profil.com/blog/topic/events) - [CRO selection (2)](https://blog.profil.com/blog/topic/cro-selection) - [Regulatory Affairs (2)](https://blog.profil.com/blog/topic/regulatory-affairs) [see all](https://blog.profil.com/blog/profil-world-1-introducing-profils-diabetes-newsletter#) ## You might also like this post ### ["What are glucose clamps and why do we need them?"](https://blog.profil.com/blog/what-are-glucose-clamps-and-why-do-we-need-them)